Investors & Partners



Selecta Biosciences and Cartesian Therapeutics have merged. For investor information, please click here.

For Cartesian’s corporate presentation, please click here.


We welcome strategic collaborations that expand the therapeutic applications of our technology platform for autoimmune diseases.


Our research has been recognized by over $7 million in competitive grant funding from the National Institutes of Health (NIH) and the Maryland Stem Cell Research Fund (MSCRF). We are grateful to our funding partners for helping to pioneer mRNA Cell Therapies.

Contact Us

If you are interested in exploring a partnership with us, please contact us at

Scroll to Top